Prognostic factors for locoregional recurrences in colon cancer

Annals of Surgical Oncology

Volumn 19, Issue 7, 2012, Pages 2203-2211

  Elferink, M A G ^a   Visser, O ^a   Wiggers, T ^b   Otter, R ^a,b   Tollenaar, R A E M ^c   Langendijk, J A ^b   Siesling, S ^a,d  

^a Department of Registration and Research   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER LOCALIZATION; CANCER PATIENT; CANCER PROGNOSIS; CANCER RISK; CANCER SURGERY; COLON CARCINOMA; COLON RESECTION; DISEASE SEVERITY; FEMALE; HIGH RISK PATIENT; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; RECURRENCE RISK; RECURRENT CANCER; RISK ASSESSMENT;

AGED; COLONIC NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NETHERLANDS; PROGNOSIS; RISK FACTORS;

EID: 84865128545     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-2183-4     Document Type: Article

References (25)

1. Comprehensive Cancer Centres. Available: http://www.cancer registry.nl. Accessed 18 May 2009.
2. Statistics Netherlands. Available: http://statline.cbs.nl/StatWeb. Accessed 3 May 2009.
3. Gatta G, Faivre J, Capocaccia R, Ponz de Leon M. Survival of colorectal cancer patients in Europe during the period 1978-1989. EUROCARE Working Group. Eur J Cancer. 1998; 34(14 Spec No):2176-83. (Pubitemid 29036883)
4. Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg. 1998;133(8):894-9. (Pubitemid 28374285)
5. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345(9):638-46.
6. Lemmens VE, van Steenbergen LV, Janssen-Heijnen M, Martijn H, Rutten H, Coebergh JW. Trends in colorectal cancer in the south of the Netherlands 1975-2007: rectal cancer survival levels with colon cancer survival. Acta Oncol. 2010 April 29.
7. Thomson WH, Foy CJ, Longman RJ.The natureoflocal recurrence after colorectal cancer resection. Colorectal Dis. 2008;10(1): 69-74. (Pubitemid 350238566)
8. Hall NR, Finan PJ, Brown S, al-Jaberi T, Tsang CS. Comparison of prognosis in cancer of the colon and rectum. Colorectal Dis. 2000;2(3):159-64.
9. Sjovall A, Granath F, Cedermark B, Glimelius B, Holm T. Loco-regional recurrence from colon cancer: a population-based study. Ann Surg Oncol. 2007;14(2):432-40. (Pubitemid 46175286)
10. Dorrance HR, Docherty GM, O'Dwyer PJ. Effect of surgeon specialty interest on patient outcome after potentially curative colorectal cancer surgery. Dis Colon Rectum. 2000;43(4):492-8. (Pubitemid 30225431)
11. Harris GJ, Church JM, Senagore AJ et al. Factors affecting local recurrence of colonic adenocarcinoma. Dis Colon Rectum. 2002;45(8):1029-34.
12. Manfredi S, Bouvier AM, Lepage C, Hatem C, Dancourt V, Faivre J: Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population. Br J Surg. 2006;93(9):1115-22. (Pubitemid 44343509)
13. McArdle CS, Hole D. Impact of variability among surgeons on postoperative morbidity and mortality and ultimate survival. BMJ. 1991;302(6791):1501-5.
14. Visser O, Coebergh JWW, van Dijck JAAM, Siesling S. Incidence of cancer in the Netherlands 1998. Utrecht: Vereniging van Integrale Kankercentra; 2002.
15. International Classification of Diseases for Oncology. 3rd edn. Geneva: WHO; 1976.
16. Hermanek P, Hutter R, Sobin L, Wagner G, Wittekind C, editors. TNM Atlas. 4th edn. Berlin: Springer-Verlag; 1997.
17. National Working Group on Gastrointestinal Cancers. Available: Guidelines colon cancer: http://www.oncoline.nl. Accessed 18 Jan 2011.
18. Snaebjornsson P, Jonasson L, Jonsson T, Moller PH, Theodors A, Jonasson JG. Colon cancer in Iceland-a nationwide comparative study on various pathology parameters with respect to right and left tumor location and patients age. Int J Cancer. 2010;127(11): 2645-53.
19. Enker WE, Thaler HT, Cranor ML, Polyak T. Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg. 1995;181(4):335-46.
20. Peeters KC, Marijnen CA, Nagtegaal ID et al. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg. 2007;246(5):693-701. (Pubitemid 350035641)
21. Hohenberger W, Weber K, Matzel K, Papadopoulos T, Merkel S. Standardized surgery for colonic cancer: complete mesocolic excision and central ligation-technical notes and outcome. Colorectal Dis. 2009;11(4):354-64.
22. Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst. 2007;99(6):433-41. (Pubitemid 47073566)
23. Moertel CG, Fleming TR, MacDonald JS et al. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Intern Med. 1995;122(5):321-6.
24. Sargent D, Sobrero A, Grothey A et al. Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20, 898 patients on 18 randomized trials. J Clin Oncol. 2009;27(6):872-7.
25. Jeffery M, Hickey BE, Hider PN. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev. 2007;(1):CD002200.